New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 22, 2013
08:32 EDTSNYGenzyme receives positive CHMP opinion for once-daily, oral AUBAGIO
Genzyme, a Sanofi Company, announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion regarding the approval of once-daily, oral AUBAGIO for the treatment of adult patients with relapsing-remitting multiple sclerosis. The CHMP did not recommend that AUBAGIO receive a new active substance designation. Additional marketing applications for AUBAGIO are under review by regulatory authorities around the world.
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
11:19 EDTSNYSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information
December 4, 2014
11:12 EDTSNYSanofi diabetes sales head left company, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use